Paying Parties
Edge Media LLC campaign for ATNM
| Emails Sent: | 6 | ||
| Estimated volume generated: | $1,667,116 | ||
| Total Paid: | $60,000 | ||
View this email in your browser
Good morning members, We saw a halt this afternoon in trading of Actinium's securities which sent it on a roller coaster ride awaiting a substantial announcement by the company. A lot of you are wondering why the stock went up after an offering was announced at a 15% discount to the market. Let me explain… The key here
...read more
| Promoter: | Otcbb Journal |
| Stocks covered: | Compensation: | Avg $ Volume for Period: |
| ATNM | $60,000 | UNKNOWN |
| Max Profit: 6.25 % | Gain at close: -5.94 % |
View this email in your browser
Good morning members, We saw a halt this afternoon in trading of Actinium's securities which sent it on a roller coaster ride awaiting a substantial announcement by the company. A lot of you are wondering why the stock went up after an offering was announced at a 15% discount to the market. Let me explain…
...read more
| Promoter: | Stocks Impossible |
| Stocks covered: | Compensation: | Avg $ Volume for Period: |
| ATNM | $60,000 | UNKNOWN |
| Max Profit: 6.25 % | Gain at close: -5.94 % |
Biotech play with near term catalysts' Jun 02, 2015
View this email in your browser
Good morning everyone, Our own Small-Cap oracle has identified this potentially undervalued biotech play. Actinium Pharmaceuticals Inc. (NYSE-MKT: ATNM) “There are three targeted therapies for attacking cancerous cells in the human body: alpha-emitters, beta-emitters, and toxins. The company competes with one other
...read more
| Promoter: | First Penny Picks |
| Stocks covered: | Compensation: | Avg $ Volume for Period: |
| ATNM | $60,000 | 1,667,116 |
| Max Profit: 6.25 % | Gain at close: -5.94 % |
Biotech play with near term catalysts' Jun 02, 2015
View this email in your browser
Good morning everyone, Our own Small-Cap oracle has identified this potentially undervalued biotech play. Actinium Pharmaceuticals Inc. (NYSE-MKT: ATNM) “There are three targeted therapies for attacking cancerous cells in the human body: alpha-emitters, beta-emitters, and toxins. The company competes with one other
...read more
| Promoter: | Stocks Impossible |
| Stocks covered: | Compensation: | Avg $ Volume for Period: |
| ATNM | $60,000 | 1,667,116 |
| Max Profit: 6.25 % | Gain at close: -5.94 % |
Biotech play with near term catalysts' Jun 02, 2015
View this email in your browser
Good morning everyone, Our own Small-Cap oracle has identified this potentially undervalued biotech play. Actinium Pharmaceuticals Inc. (NYSE-MKT: ATNM) “There are three targeted therapies for attacking cancerous cells in the human body: alpha-emitters, beta-emitters, and toxins. The company competes with one other
...read more
| Promoter: | Otcbb Journal |
| Stocks covered: | Compensation: | Avg $ Volume for Period: |
| ATNM | $60,000 | 1,667,116 |
| Max Profit: 6.25 % | Gain at close: -5.94 % |
Biotech play with several near term catalysts' Jun 02, 2015
View this email in your browser
Good morning everyone, Our own Small-Cap oracle has identified this potentially undervalued biotech play. Actinium Pharmaceuticals Inc. (NYSE-MKT: ATNM) “There are three targeted therapies for attacking cancerous cells in the human body: alpha-emitters, beta-emitters, and toxins. The company competes with one other
...read more
| Promoter: | Street Picks |
| Stocks covered: | Compensation: | Avg $ Volume for Period: |
| ATNM | $60,000 | 1,667,116 |
| Max Profit: 6.25 % | Gain at close: -5.94 % |